Skip to content

A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect

TEE-guided Perventricular Device Closure Through Minithoracotomy vs Traditional Surgery Repair Via CBP in Treatment of Infundibular Ventricular Septal Defect:A Two-center Clinical Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02361008
Enrollment
20121212
Registered
2015-02-11
Start date
2012-12-31
Completion date
2014-12-31
Last updated
2015-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Double Outlet Right Ventricle, Noncommitted VSD, Double Outlet Right Ventricle, Subaortic VSD, Double Outlet Right Ventricle, Subpulmonary VSD, Heart Septal Defects, Ventricular, Supracristal Ventricular Septal Defect

Keywords

Infundibular Ventricular Septal Defect, occlusion, TEE-guided, asymmetric occluder, surgical repair

Brief summary

The purpose of this study is to investigate the security and validity of transesophageal echocardiography(TEE)-guided perventricular device closure(TPDC) through minithoracotomy in treatment of infundibular ventricular septal defect(IVSD) with asymmetric occluder.

Detailed description

Ventricular septal defect(VSD) , which accounted for about 20% of all congenital heart defects (CHDs) , is among the most common congenital heart malformations,among which infundibular ventricular septal defects(IVSD) is the least common type(18%).Multiple names for IVSD are in use. They can also be labeled conal VSD, subpulmonary VSD, subarterial VSD, doubly committed VSD, intracristal VSD,or supracristal VSD. These multiple denominations are not attached to specifically different anatomic subtypes.At present, the main methods to treat the specific anatomic condition contain conventional surgical repair(SR) and transcatheter interventional closure. The former need extracorporeal circulation,thus the side effects of extracorporeal circulation are inevitable,such as on the central nervous system, respiratory system, urinary system, etc. Although the latter has the characteristics of minimally invasive, patients should be exposed in X-ray withstanding potential risk of radiation. On the other hand,there are limits with age for patients who underwent transcatheter closure because of small vessel size. Fully developed blood vessels are to reach a certain diameter, but children need be up to 3 years old or so. In addition,the aortic valve was easily injured by wire and atrioventricular block was reported.Since the surrounding structure is complicated and the defect is too high, device closure of an IVSD is difficult to succeed in transcatheter approach. Traditional repair via cardiopulmonary bypass(CBP) is widely used to treat this kind of diseases. Past decade,with the development of technology and society,TEE-guided surgical occlusion through minithoracotomy was used to treat CHDs in an increasing number of popularity,avoiding the inherent risks of cardiopulmonary bypass and radiation,etc. But it is rarely reported to treat IVSD by minimally invasive perventricular device closure without CBP.

Interventions

PROCEDURESurgery repair with CBP

Traditional surgery repair under the CBP.

DEVICETEE-guided perventricular device closure without CBP

Perventricular device closure through minithoracotomy under the TEE-guidance without CBP.The device is an eccentric occluder made by Shanghai Shape Memory Alloy Co.,Ltd in Shanghai,China

Sponsors

The Third Affiliated Hospital of Nanchang University
CollaboratorOTHER
Bentong Yu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
7 Days to 70 Years
Healthy volunteers
No

Inclusion criteria

(1) patients with single IVSD indicated by TTE,without concomitant cardiac malformation, serious arrhythmia or other important non-cardiac diseases;(2) patients whose ventricular septal defects from aortic residual \< 3 mm, preoperative without aortic regurgitation or only mild reflux, defect size ≤10 mm;

Exclusion criteria

(1) defect size \> 10 mm in diameter; (2) Preoperative with above moderate aortic valve prolapse (or) closed incompletely; (3) Eisenmenger syndrome caused by pulmonary hypertension,(4)decide temporarily to change method before surgery;(5) not signed informed consent application

Design outcomes

Primary

MeasureTime frameDescription
Surgery success ratetwo monthsSurgery success means that patients in both TPDC and SR group don't change their surgery type either undergo a repeat surgery.

Secondary

MeasureTime frameDescription
Hospitalization costs1 monthsThe hospitalization costs calculated from hospital admission to hospital discharge

Other

MeasureTime frameDescription
Length of hospital stay (post-op)1 monthsLength of hospital stay refers in particular to the post-op stay in hospital.
Mean bleeding volume6 hoursThe mean bleeding volume only referred during the procedure
Volume of drainage1 weeksThe volume of drainage is calculated from being moved off operating table to being pulled out drainage tube.
Procedure time6 hoursThe procedure time is from skin cut to skin suture

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026